Skip to main content

IGHID Investigators Discuss Projects As New Academic Year Begins

September 1, 2022

Global health research is a collaborative process, and each researcher at the Institute for Global Health & Infectious Diseases (IGHID) contributes a piece to solving the puzzle of disease and morbidity. With a new academic year underway, read what some of our investigators are working on to improve the health of global populations. Their multi-disciplinary findings … Continued

Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women – Findings from HPTN 084 Study

August 31, 2022

Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through November 5, 2021). Read more.

Addressing Racism’s Role in the US HIV Epidemic: Qualitative Findings from Three “Ending the HIV Epidemic” Prevention Projects

August 31, 2022

Researchers from the Institute for Global Health and Infectious Diseases, the Gillings School of Global Public Health, and Center for Health Equity Research reviewed qualitative data from three “Ending the HIV Epidemic” (EHE) projects, published in the July issue of Journal of Acquired Immune Deficiency Syndrome (JAIDS). In the article, Kate Muessig, PhD, associate professor … Continued

Study shows the positive effect of preventative therapy for malaria is mediated by gestational weight gain, influenced by intestinal pathogens

August 2, 2022

Malaria in pregnancy (MiP) is a major public health problem with substantial risks for mothers and their babies. The combination treatment sulfadoxine-pyrimethamine (SP), given for intermittent preventive therapy of malaria in pregnancy (IPTp), is one of the few existing interventions that improve outcomes for both mother and baby, despite widespread SP-resistant malaria. Compelling evidence has shown malaria-independent … Continued

CDC renews five-year funding for vector-borne disease threats

August 2, 2022

The Center for Disease Control and Prevention (CDC) has announced the five-year funding renewal of the Southeastern Center for Vector-Borne Diseases (SECVBD), an interdisciplinary team of researchers that includes UNC’s Ross Boyce, MD, MSc, a member of the UNC Institute for Global Health & Infectious Diseases and assistant professor in infectious diseases and epidemiology, and … Continued

STD Awareness in April: Infectious Disease Experts Are Working to Advance the Development of Vaccines for Sexually Transmitted Infections

April 20, 2022

During April, STD Awareness provides an opportunity to talk about STIs and encourage individuals to be proactive about their sexual health and promotes regular STI/HIV screening and testing. Although research in sexually transmitted infections (STIs) has evolved rapidly on multiple fronts, a critical remaining challenge is the development of safe and effective vaccines for diseases that pose … Continued

García Receives ISAR’s 2022 Diversity Speaker Award

April 7, 2022

J. Victor García-Martinez, PhD, professor in the Division of Infectious Diseases and the Department of Microbiology & Immunology and Director of the International Center for the Advancement of Translational Science was keynote lecturer at the 35th International Conference on Antiviral Research (ICAR) last month. During the conference he was presented the second 2022 Diversity Speaker … Continued